This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Benjamin Charles Milgrim
Introduction
Benjamin Charles Milgrim is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sodium channel inhibitors. His work is essential for advancing treatments for various pain disorders and itch-related conditions.
Latest Patents
Milgrim holds a patent for "Bicyclic sulfonamide compounds as sodium channel inhibitors." This invention provides compounds of Formula I, along with pharmaceutically acceptable salts, that inhibit voltage-gated sodium channels, specifically Nav1.7. These compounds are valuable for treating diseases associated with sodium channel activity, such as pain disorders and itch. Additionally, pharmaceutical compositions containing these compounds are also included in his patent.
Career Highlights
Milgrim is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen focuses on innovative solutions in drug development, particularly in the realm of pain management and related therapeutic areas.
Collaborations
Some of his notable coworkers include Matthew M Weiss and Alessandro Boezio. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Benjamin Charles Milgrim's contributions to the field of sodium channel inhibitors highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to pave the way for new treatments that address significant medical challenges.